SYSTEMIC SCLERODERMA
Clinical trials for SYSTEMIC SCLERODERMA explained in plain language.
Never miss a new study
Get alerted when new SYSTEMIC SCLERODERMA trials appear
Sign up with your email to follow new studies for SYSTEMIC SCLERODERMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New radiation technique may protect organs in scleroderma stem cell therapy
Disease control Recruiting nowThis early-phase study tests a new way to deliver total body radiation before a stem cell transplant for people with severe systemic sclerosis (scleroderma). The goal is to see if using a precise radiation technique (IMRT) along with chemotherapy can reduce damage to the lungs an…
Matched conditions: SYSTEMIC SCLERODERMA
Phase: EARLY_PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 26, 2026 09:21 UTC
-
New hope: immune drug tested in patients with both autoimmune disease and cancer
Disease control Recruiting nowThis study is for people who have both an autoimmune disorder (like rheumatoid arthritis, lupus, or multiple sclerosis) and advanced cancer that has spread or cannot be removed. It tests a drug called nivolumab, which helps the immune system fight cancer, given alone or with othe…
Matched conditions: SYSTEMIC SCLERODERMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 18, 2026 12:09 UTC
-
Family ties to a rare disease: scientists seek clues in relatives
Knowledge-focused Recruiting nowThis study looks at people with systemic scleroderma who also have a close family member with the disease. Researchers want to understand how the disease runs in families, find markers that predict how it will progress, and identify new targets for treatments. About 20 adults wil…
Matched conditions: SYSTEMIC SCLERODERMA
Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated May 26, 2026 09:20 UTC
-
New light imaging could replace the Skin-Pinch test for scleroderma
Knowledge-focused Recruiting nowThis study tests a new, painless imaging method called spatial frequency domain imaging (SFDI) to measure skin thickness in people with scleroderma. Currently, doctors use a subjective 'pinch test' that can vary between doctors. The study will compare SFDI to the pinch test and u…
Matched conditions: SYSTEMIC SCLERODERMA
Phase: NA • Sponsor: Boston University • Aim: Knowledge-focused
Last updated May 26, 2026 08:59 UTC